Malmström U, Busch C, Norlen B J, Andersson B
Department of Urology, University Hospital, Sweden.
Eur Urol. 1990;18(2):97-100. doi: 10.1159/000463882.
The correlation of blood group to grade, stage and tumor markers at diagnosis and to the subsequent clinical course was investigated in a consecutive retrospective series of 230 patients with primary transitional cell carcinoma of the urinary bladder. The follow-up period was 5-9 years. There were no significant differences in grade, stage or DNA ploidy between patients of blood groups A and O. However, the deletion of ABH blood group isoantigen was found more frequently in tumors from patients of blood group O. Concerning progression of superficial bladder tumors, this was found earlier among patients of blood group O, and in a multivariate analysis this emerged as an independent prognostic factor. The crude and corrected mortality was not significantly higher among patients of group O than among those of other blood groups.
在一项对230例原发性膀胱移行细胞癌患者的连续回顾性系列研究中,调查了血型与诊断时的分级、分期和肿瘤标志物以及随后临床病程之间的相关性。随访期为5至9年。A血型和O血型患者在分级、分期或DNA倍体方面无显著差异。然而,在O血型患者的肿瘤中更频繁地发现ABH血型同种抗原缺失。关于浅表性膀胱肿瘤的进展,在O血型患者中发现得更早,并且在多变量分析中,这成为一个独立的预后因素。O血型患者的粗死亡率和校正死亡率并不显著高于其他血型患者。